IL6 and COVID-19: The mechanism behind the development of lymphopenia in COVID-19 is suggested to be multi-factorial: direct cell infection by the virus, indirect destruction by hyper-inflammation caused via IL-6 and TNF-α pathways, and lymphocytes recruitment to the inflammatory lung tissues [21].